Joseph Slattery
Fortune : 371 673 $ au 31/05/2026
Fortune : 371 673 $ au 31/05/2026
Mr. Joseph P.
Slattery, CPA, is an Independent Director at Replimune Group, Inc., a Lead Independent Director at CVRx, Inc. and a Member at Virginia Society of Certified Public Accountants.
He is on the Board of Directors at ImageneBio, Inc., Morphic Therapeutic, Inc., Replimune Group, Inc. and CVRx, Inc. Mr. Slattery was previously employed as an Independent Director by Omega Alpha SPAC, an Independent Director by Morphic Holding, Inc., a CFO, Chief Accounting Officer & EVP by TransEnterix, Inc., a Chief Financial Officer & Executive Vice President by SafeStitch Medical, Inc., a Chief Financial Officer & Executive Vice President by TransEnterix, Inc. /Old/, an Independent Director by Micromet, Inc. /MD/, a Chief Financial Officer & Executive Vice President by Baxano Surgical, Inc., a Chief Financial Officer & SVP-Information Systems by Digene Corp., a Staff Auditor by Ernst & Young LLP, and an Audit Manager by KPMG LLP.
He also served on the board at Exosome Diagnostics, Inc. and Micromet, Inc. He received his undergraduate degree from Bentley University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CVRX, INC. 0,15 % | 01/06/2026 | 39 365 ( 0,15 % ) | 219 657 $ | 31/05/2026 |
0,14 % | 28/04/2026 | 16 000 ( 0,14 % ) | 94 080 $ | 31/05/2026 |
REPLIMUNE GROUP, INC. 0,01 % | 01/04/2026 | 6 667 ( 0,01 % ) | 57 936 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CVRX, INC. | Directeur/Membre du Conseil | 01/10/2008 |
| REPLIMUNE GROUP, INC. | Directeur/Membre du Conseil | 01/10/2017 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Directeur/Membre du Conseil | 01/05/2019 |
Virginia Society of Certified Public Accountants | Corporate Officer/Principal | 28/06/2010 |
| Sociétés | Poste | Fin |
|---|---|---|
| MORC HOLD | Directeur/Membre du Conseil | 16/08/2024 |
| ASENSUS SURGICAL, INC. | Directeur Financier/CFO | 31/12/2019 |
TransEnterix, Inc. /Old/
TransEnterix, Inc. /Old/ Medical SpecialtiesHealth Technology Develops tools and technique for gastro-intestinal surgical procedure | Directeur Financier/CFO | 01/12/2019 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Directeur/Membre du Conseil | 01/01/2018 |
SafeStitch Medical, Inc.
SafeStitch Medical, Inc. Medical SpecialtiesHealth Technology Produces medical devices | Directeur Financier/CFO | 09/12/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 17 |
|---|---|
Digene Corp.
Digene Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets DNA and RNA tests | Electronic Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
TransEnterix, Inc. /Old/
TransEnterix, Inc. /Old/ Medical SpecialtiesHealth Technology Develops tools and technique for gastro-intestinal surgical procedure | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology Designs and develops surgical procedures and equipment for back pain | Health Technology |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Virginia Society of Certified Public Accountants | |
SafeStitch Medical, Inc.
SafeStitch Medical, Inc. Medical SpecialtiesHealth Technology Produces medical devices | Health Technology |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Health Services |
Asensus Surgical, Inc.
Asensus Surgical, Inc. Packaged SoftwareTechnology Services Develops digital and robotic-assisted surgical systems | Technology Services |
Replimune Group, Inc.
Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Omega Alpha SPAC
Omega Alpha SPAC Financial ConglomeratesFinance Operates as a blank check company | Finance |
Micromet Inc.
Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national